Personal information

Websites & social links

researchmap
LinkedIn

Activities

Collapse all

Employment (1)

Japanese Foundation for Cancer Research: Tokyo, JP

Project Scientist (Division of Pathology)
Employment
Source: Self-asserted source
Naoko Tsuyama

Education and qualifications (2)

University of Tsukuba: Tsukuba, Ibaraki, JP

MD (School of Medicine)
Education
Source: Self-asserted source
Naoko Tsuyama

Tokyo Medical and Dental University: Tokyo, JP

PhD (Comprehensive pathology)
Education
Source: Self-asserted source
Naoko Tsuyama

Works (15)

BCL2 expression in DLBCL: reappraisal of immunohistochemistry with new criteria for therapeutic biomarker evaluation.

2017-05 | Journal article
DOI: 10.1182/blood-2016-12-759621
PMID: 28522442
Contributors: Tsuyama N; Sakata S; Baba S; Mishima Y; Nishimura N; Ueda K; Yokoyama M; Terui Y; Hatake K; Kitagawa M et al.
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.

2017-05 | Journal article
DOI: 10.18632/oncotarget.16532
PMID: 28380441
PMC: PMC5464884
Contributors: Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Intravascular Large B-cell Lymphoma of the Bilateral Ovaries and Uterus in an Asymptomatic Patient with a t(11;22)(q23;q11) Constitutional Translocation.

2016 | Journal article
DOI: 10.2169/internalmedicine.55.6578
PMID: 27803414
PMC: PMC5140869
Contributors: Shigematsu Y; Matsuura M; Nishimura N; Tsuyama N; Takeuchi K; Terui Y; Takeshima N; Hatake K
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Extranodal NK/T-cell lymphoma, nasal type, manifesting as rapidly progressive dementia without any mass or enhancing brain lesion.

2016-10 | Journal article
DOI: 10.1111/neup.12285
PMID: 26773724
Contributors: Shimatani Y; Nakano Y; Tsuyama N; Murayama S; Oki R; Miyamoto R; Murakami N; Fujita K; Watanabe S; Uehara H et al.
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Frequent BCOR aberrations in extranodal NK/T-Cell lymphoma, nasal type.

2016-05 | Journal article
DOI: 10.1002/gcc.22348
PMID: 26773734
Contributors: Dobashi A; Tsuyama N; Asaka R; Togashi Y; Ueda K; Sakata S; Baba S; Sakamoto K; Hatake K; Takeuchi K
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

ALK-positive large B-cell lymphoma: identification of EML4-ALK and a review of the literature focusing on the ALK immunohistochemical staining pattern.

2016-04 | Journal article
DOI: 10.1007/s12185-016-1934-1
PMID: 26781614
Contributors: Sakamoto K; Nakasone H; Togashi Y; Sakata S; Tsuyama N; Baba S; Dobashi A; Asaka R; Tsai CC; Chuang SS et al.
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Biweekly THP-COP therapy for newly diagnosed peripheral T-cell lymphoma patients.

2015-03 | Journal article
DOI: 10.1002/hon.2136
PMID: 24519501
Contributors: Tomita N; Kodama F; Tsuyama N; Sakata S; Takeuchi K; Ishibashi D; Koyama S; Ishii Y; Yamamoto W; Takasaki H et al.
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Absolute peripheral monocyte count at diagnosis predicts central nervous system relapse in diffuse large B-cell lymphoma.

2015-01 | Journal article
DOI: 10.3324/haematol.2014.114934
PMID: 25261092
PMC: PMC4281317
Contributors: Nitta H; Terui Y; Yokoyama M; Mishima Y; Nishimura N; Ueda K; Kusano Y; Tsuyama N; Takeuchi K; Kanda Y et al.
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Pathology of indolent B-cell neoplasms other than follicular lymphoma.

2014 | Journal article
DOI: 10.3960/jslrt.54.11
PMID: 24942942
Contributors: Sakata S; Tsuyama N; Takeuchi K
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.

2014-02 | Journal article
DOI: 10.1038/ng.2872
PMID: 24413737
Contributors: Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y et al.
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

MIB-1 labeling index as a prognostic factor for patients with follicular lymphoma treated with rituximab plus CHOP therapy.

2013-12 | Journal article
DOI: 10.1111/cas.12288
PMID: 24112697
Contributors: Yamamoto E; Tomita N; Sakata S; Tsuyama N; Takeuchi K; Nakajima Y; Miyashita K; Tachibana T; Takasaki H; Tanaka M et al.
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Prognostic value of high thymidine kinase activity in patients with previously untreated diffuse large B-cell lymphoma treated by rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone.

2013-11 | Journal article
DOI: 10.3109/10428194.2013.779690
PMID: 23488601
Contributors: Suzuki K; Terui Y; Yokoyama M; Ueda K; Nishimura N; Mishima Y; Sakajiri S; Tsuyama N; Takeuchi K; Hatake K
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy.

2013-09 | Journal article
DOI: 10.3109/10428194.2012.754023
PMID: 23216271
Contributors: Ueda K; Terui Y; Yokoyama M; Sakajiri S; Nishimura N; Tsuyama N; Takeuchi K; Hatake K
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

Prognostic significance of programmed cell death-1-positive cells in follicular lymphoma patients may alter in the rituximab era.

2013-04 | Journal article
DOI: 10.1111/ejh.12075
PMID: 23331211
Contributors: Takahashi H; Tomita N; Sakata S; Tsuyama N; Hashimoto C; Ohshima R; Matsuura S; Ogawa K; Yamamoto W; Kameda Y et al.
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central

A low-grade B-cell lymphoma with prolymphocytic/paraimmunoblastic proliferation and IRF4 rearrangement.

2013-03 | Journal article
DOI: 10.3324/haematol.2012.076851
PMID: 23300175
PMC: PMC3659954
Contributors: Takeuchi K; Sakata S; Asaka R; Tsuyama N; Dobashi A; Noguchi M
Source: Self-asserted source
Naoko Tsuyama via Europe PubMed Central
How many people are using ORCID?